FDA staff blindsided by move allowing more e-cigarettes and nicotine pouches onto US market
Senior officials within the Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) were reportedly blindsided by a recent internal decision to allow a broader range of unauthorized e-cigarettes and nicotine pouches to remain on or enter the U.S. market. This move, learned via The Associated Press, signals a significant shift in the agency’s enforcement posture regarding products that have not yet received marketing authorization through the stringent Premarket Tobacco Product Applications (PMTAs) pathway.











